
WuXi Biologics has been recognized for its outstanding sustainability efforts by being included in the 2026 Dow Jones Best-in-Class World Index and Emerging Markets Index. This inclusion reflects the company's top 10% ranking globally in environmental, social, and governance (ESG) performance, based on S&P Global's Corporate Sustainability Assessment. The company has also been featured in the S&P Global Sustainability Yearbook for the fourth consecutive year and holds multiple high ESG ratings from leading agencies. WuXi Biologics plans to continue integrating ESG principles into its business strategy and operations to promote sustainable practices across its value chain.